DPIIT recognised startup Government of India
Startup India
Amerise Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.18 Cr
▲ 98% YoY
Net profit · FY 2025
₹10.55 Lakh
Net margin 4.8%
EBITDA · FY 2025
₹51.06 Lakh
EBITDA margin 23.4%
Authorised capital
₹6.1 Cr
Registered with MCA
Paid-up capital
₹4.87 Cr
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
1
Provident fund records
Directors on board
2
As per MCA filings
About Amerise Pharmaceuticals Private Limited
Data last updated:
Amerise Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Halewood Laboratories Private Limited and recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U36900GJ2018PTC104672. Its GSTIN is 24AARCA4430E1ZX (Gujarat).
The company has an authorised share capital of ₹6.1 Cr and a paid-up capital of ₹4.87 Cr. It is led by directors Jalpaben Niravkumar Vyas and Nirav Nalinkumar Vyas.
Its last annual general meeting (AGM) was held on 20 July 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.18 Cr, a growth of 98% compared to the previous year. For the same year it recorded a net profit of ₹10.55 Lakh (net margin 4.8%) and EBITDA of ₹51.06 Lakh (EBITDA margin 23.4%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 1% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Amerise Pharmaceuticals.
Amerise Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0118925). For more details, the company can be reached via its website amerisepharma.com.
Company details
CIN U36900GJ2018PTC104672
Registration Number 104672
Incorporation Date 09 October 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 July 2024
Date of Balance Sheet 31 March 2024
Parent Company Halewood Laboratories Private Limited
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0118925
Recognitions & Rankings of Amerise Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0118925
Contact details
Amerise Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is amerisepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address709 Aaron Spectra Rajpath Rangoli Road, Behind Rajpath Club Bodakdev, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Amerise Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Amerise Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Amerise Pharmaceuticals operates one associated brand: Amerise Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of drug research & development services for multiple therapeutic areas | amerisepharma.com |
Business activity
The main business activity of Amerise Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Amerise Pharmaceuticals Private Limited, buy the company report.
Financials of Amerise Pharmaceuticals Private Limited
FY 2024 filings availableAmerise Pharmaceuticals Private Limited reported revenue of ₹2.18 Cr (up 98% YoY) for FY 2025.
Revenue · FY 2025
₹2.18 Cr ▲ 98%
Net profit · FY 2025
₹10.55 Lakh margin 4.8%
EBITDA · FY 2025
₹51.06 Lakh margin 23.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 98%
3 years · compounded
▼ 34%
5 years · compounded
▲ 1%
EBITDA CAGR growth
3 years · compounded
▼ 16%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 98% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.4% | ||||
| Net Profit Margin | 4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amerise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amerise Pharmaceuticals Private Limited
Amerise Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jalpaben Niravkumar Vyas | Director | 09 Oct 2018 | 8 Years 1 Months | Current |
| Nirav Nalinkumar Vyas Also directs: Amerigen Life Sciences LLP, Amuna Pharmaceuticals LLP, Avimn Pharmaceuticals LLP and 1 more | Director | 04 Sep 2021 | 5 Years 2 Months | Current |
Auditor
Amerise Pharmaceuticals Private Limited is audited by B K Patel & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B K Patel & Co. | FY 2022 | 112647W |
Shareholding
The shareholding of Amerise Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Amerise Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amerise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amerise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Amerise Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Amerise Pharmaceuticals Private Limited, buy the company report.
GST
Amerise Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AARCA4430E1ZX | Gujarat | Active | 27 Nov 2018 |
To see the full GST registrations and return filing status of Amerise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amerise Pharmaceuticals Private Limited has 10 board changes on record since 2018: 6 appointments and 4 cessations. The latest: Krutin Kaushik Chaturvedi ceased to be Director on 04 Feb 2023.
AGM
Amerise Pharmaceuticals Private Limited last Annual general meeting of members was held on 20 Jul 2024 as per latest MCA records.
Filing
Amerise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Krutin Kaushik Chaturvedi ceased to be Director.
Ceased
Sanchit Kaushik Chaturvedi ceased to be Director.
Appointed
Nirav Nalinkumar Vyas was appointed as Director.
Appointed
Krutin Kaushik Chaturvedi was appointed as Director.
Ceased
Nileshbhai Yadav ceased to be Director.
Appointed
Sanchit Kaushik Chaturvedi was appointed as Director.
Ceased
Payal Vinodkumar Patel ceased to be Director.
Appointed
Nileshbhai Yadav was appointed as Director.
Appointed
Jalpaben Niravkumar Vyas was appointed as Director.
Appointed
Payal Vinodkumar Patel was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Amerise Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2018 (8+ years old) and is registered under CIN U36900GJ2018PTC104672.
Amerise Pharmaceuticals has 2 current directors:
- Jalpaben Niravkumar Vyas - Director
- Nirav Nalinkumar Vyas - Director
The latest financial statements of Amerise Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 20 July 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Amerise Pharmaceuticals is 24AARCA4430E1ZX, registered in Gujarat.
The CIN (Corporate Identification Number) of Amerise Pharmaceuticals is U36900GJ2018PTC104672. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amerise Pharmaceuticals was incorporated on 09 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Krutin Kaushik Chaturvedi ceased to be Director on 04 Feb 2023. Sanchit Kaushik Chaturvedi ceased to be Director on 04 Feb 2023. Nirav Nalinkumar Vyas was appointed as Director on 04 Sep 2021. Amerise Pharmaceuticals has 10 board changes on record in total.
Yes, Amerise Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Amerise Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0118925).
Amerise Pharmaceuticals can be reached through the website amerisepharma.com. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages